CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for 20/20 Biolabs Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

20/20 Biolabs Inc
9430 Key West Avenue, Suite 100
Phone: (240) 453-6339p:240 453-6339 ROCKVILLE, MD  20850  United States Ticker: AIDXAIDX
Business Summary
20/20 BioLabs, Inc. develops and commercializes artificial intelligence (AI)-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. The Company offers two families of lab tests under the OneTest brand. OneTest for Cancer is a multi-cancer early detection blood test and OneTest for Longevity measures inflammatory biomarkers and is commercially available. OneTest's tests are designed to be utilized at home using new, upper-arm capillary collection devices as an alternative to traditional venipuncture. Tests are run in the Company's College of American Pathologists (CAP) accredited, Clinical Laboratory Improvement Amendments (CLIA) licensed laboratory in Gaithersburg, Maryland. Its protein tumor marker approach is the multi-cancer early detection (MCED) blood test that detects multiple cancers including lung, pancreatic, ovarian, and liver at earlier, more treatable stages than competing, deoxyribonucleic acid (DNA) based MCEDs.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202612/31/2025YesYes---

Industries
SIC Code Description
3826 Laboratory analytical instruments
8734 Testing laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board John G.Compton 77 7/1/2016 7/1/2016
President, Chief Executive Officer, Director JonathanCohen 63 1/1/2025 1/1/2025
Chief Financial Officer AlanBergman 57 2/1/2026 12/1/2025
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 4 (As of 12/31/2025)
Outstanding Shares: 13,367,204 (As of 10/20/2026)
Stock Exchange: NASD
Federal Tax Id: 522272107
Fax Number: (240) 403-0289


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, November 14, 2026